KRISTEN WISSBAUM: Open Payments
NPI 1356972483 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$303 in 14 payments from 12 companies in 2025. Trend: 2023 $1,106 · 2024 $895 · 2025 $303
Food & beverage: $303
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Janssen Biotech, Inc. | 2 | $39 |
| Merck Sharp & Dohme LLC | 1 | $30 |
| ABBVIE INC. | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $27 |
| TAIHO ONCOLOGY, INC. | 1 | $24 |
| Fennec Pharmaceuticals, Inc. | 1 | $24 |
| KYOWA KIRIN, INC. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Eisai Inc. | 1 | $17 |
Products named: KEYTRUDA, CREON, Enhertu, DARZALEX, LONSURF, Fyarro, CALQUENCE, POTELIGEO.
Industry payments across NC — which companies pay providers there.
